Mile 20 and the Screening Gap: Mass-Participation Marathons Are Outgrowing the System That Protects Them

At mile 18 of the Portland Marathon, a woman stood at the roadside waiting for her husband. When he reached her, they paused for a few seconds — a brief kiss amid the sound of shoes striking asphalt and the scattered cheers of the crowd. Then he ran on. Two miles later, at mile 20, roughly 32 kilometres, Trey Lara collapsed. He was taken for emergency care. Days later, with only a few days remaining before his twenty-fifth birthday, he died. The initial cause was described by his family and by the media as sudden cardiac arrest. That is everything we know for certain about the mechanism of death. Thirty years behind the locker-room door, I know that the smell of victory and the smell of tears are no different — and I also know that in stories like this, the most dangerous thing is to conclude too soon. I have stood in the locker-room corridor many times in my career, waiting for an athlete who had just lost or just won. I learned that the true moment of a race is not at the finish line. It lives in the seconds before someone steps out onto the course, in the way they tie their laces, in the unsettled rhythm of their breathing, in a glance toward the stands. For a recreational runner, that moment is usually recorded by no one. No camera, no reporter, no results board. Only a fall morning, a set of running clothes, and a belief that the body will carry them across the line. The Portland Marathon is one of the oldest and most heavily attended road races in the United States, traditionally held in autumn. It is an open event: anyone who registers and pays the fee can step onto the course, with no qualifying standard and no invitation. The organiser named in this case is Motiv Sports, whose executive director is Crystian Kumnick. Trey Lara was not a professional athlete. He was a young pastor who worked with teenagers in his community. He entered the marathon with a simple goal: to relax and relieve stress. He had trained for many months before race day. He prepared seriously, in the way that hundreds of thousands of recreational runners around the world prepare. The central question of this story does not lie in performance. No finish time was published, no split data, no average pace. In a case like this, any attempt to speculate about the runner's fitness or tactics is baseless speculation. The analytical centre of gravity lies elsewhere: in cardiac physiology, in the medical-safety infrastructure of mass-participation races, and in the screening gap the mass-marathon system leaves behind. Based on my experience covering road racing across several decades, what stands out here is the contrast between the scale of the movement and the thinness of the protective layer. Mass marathon participation has exploded in numbers over two decades. The cardiac-screening infrastructure serving it has barely moved. One point must be stated at the outset: sudden cardiac arrest and myocardial infarction are two different things. The American Heart Association distinguishes them clearly, and that distinction is decisive in the case of a young person. Myocardial infarction, the event we commonly call a heart attack, occurs when blood flow to the heart muscle is blocked, usually by atherosclerotic plaque. That mechanism dominates in older runners. In a twenty-five-year-old, the picture is almost certainly different. Sudden cardiac arrest in the young usually originates in an arrhythmia, an electrical fault in the heart, or in a structural abnormality the person was born with. The fact that the original report cites the American Heart Association definition is a telling detail. It suggests the mechanism may involve electrical or structural factors, rather than necessarily being a heart attack caused by coronary blockage. There is an epidemiological point worth separating out. In older runners, the leading cause of cardiac events during exertion is usually coronary disease, that is, atherosclerosis accumulated with age. In the young, the picture reverses. Coronary disease is rare; instead, congenital and electrical abnormalities dominate. This distinction matters because it determines the type of screening required. A fifty-year-old needs coronary risk assessment. A twenty-five-year-old needs screening for structural and electrical abnormalities. Two different problems, two different tools. Within Trey Lara's age group, the medical literature points to several leading causes. Hypertrophic cardiomyopathy is a genetically driven thickening of the heart muscle and a leading cause of sudden death in the young. Congenital coronary anomalies occur when the vessels supplying the heart run on the wrong path from birth. Ion-channel disorders, such as long-QT syndrome, CPVT or Brugada, are electrical conditions that can cause fatal arrhythmias without any structural abnormality. Alongside these are myocarditis, an inflammation of the heart muscle often following a viral infection and linked to sudden death in young adults, and exercise-associated hyponatremia, a dangerously low blood-sodium level caused by drinking too much fluid during a race — a cause of collapse and cardiac arrest that few runners consider. What most of these conditions share is silence. A person carrying hypertrophic cardiomyopathy may live entirely normally, without symptoms or signs, until the day the event occurs. The same is true of someone with an ion-channel disorder. These conditions do not surface in routine check-ups. They are not detected by a simple fitness examination or a history questionnaire. This is why the family's assertion that the victim was completely healthy, with no underlying disease, should be read as the testimony of loved ones, not as a medical conclusion. The original report itself carefully notes this: no medical conclusion has ruled out a hidden abnormality. That caution deserves recognition, because it keeps the story from sliding into judgment. Mile 20, the point at which the runner collapsed, is not a random marker. In marathon running, the final third of the race is the segment where cumulative cardiac and thermoregulatory strain peaks. Heart rate has been sustained in a high zone for hours. Core temperature rises steadily. Fluid and electrolytes lost through sweat may not have been fully replaced. The body is now operating near its threshold, and with a heart carrying a hidden abnormality, that threshold can be crossed without any prior warning. That the runner collapsed at mile 20, two miles after meeting his wife at mile 18, tells us only the location. It tells us nothing about pace, heart rate, or effort in the preceding miles. No split data was published. Any speculation about whether a pace-related or effort-related factor preceded the event lies beyond the reach of the available facts. The detail that he trained for many months is the only preparation datum we have. It is too coarse to assess training-load management, but it shows this was not an impulsive decision. At the same time, it suggests a familiar profile: a first-time marathoner, self-coached, with no coach, no training group, no sports physician monitoring. Within this group, event-related risk tends to be higher, because the runner is less familiar with pacing discipline and less attuned to the body's warning signals under prolonged exertion. Nothing in the source allows us to conclude that this person trained too much or too little. Both possibilities are conceivable, and neither is supported. What is more certain is the protective layer that recreational runners lack. Elite athletes usually have medical staff close by, someone tracking training load, and periodic cardiac screening. Recreational runners manage alone. No one monitors them between long runs. No one knows how their resting heart rate shifts week to week. International studies estimate the risk of cardiac death during marathon running at roughly 0.5 to 1 per 100,000 participants. This figure lies outside the source material and requires independent verification, but it offers a reference frame: the risk is very low at the individual level, yet far from negligible at the population level. For a race with fifty thousand participants, the probability of such an event occurring within the event is not something that can be dismissed. Picture the structure of a modern marathon as a pyramid. At the peak are the elite, those running under two hours twenty, with their own medical teams, doctors watching, and periodic cardiac screening. Next comes the sub-elite. Then the largest tier: recreational runners. And at the base, the group at highest medical risk: first-time marathoners. The paradox is that the best-protected group is the smallest, and the largest group is the most thinly protected. An elite athlete steps onto the course with an electrocardiogram, an echocardiogram and full blood work in their file. A recreational runner steps onto the same course with very little of the same. No ECG. No echocardiogram. No one asking whether they have ever fainted during exertion, or whether a relative died young. This is a systemic gap, not an individual failing. In the United States, entering a mass-participation marathon does not require cardiac screening. Runners self-report their health, sign a liability waiver, and take to the course. The system works this way for many reasons: cost, feasibility, and a practical reality — there are not enough resources to provide advanced cardiac screening to millions of runners each year. The price of that gap is paid in cases like this. I do not write about the results board; I write about what is overlooked. People ask what women understand about tactics. I answer by counting an athlete's breaths from the stands, more precisely than a stopwatch. In this case, what deserves counting is not the cadence of footsteps, but the heartbeat no one measured before it was too late. The first public reaction to a death on a marathon course is usually to blame the race itself. People point to the distance, the temperature, the harshness of the sport. I believe that attribution points in the wrong direction. The marathon does not kill by itself. It is only a test. It exposes something that already existed, silently, inside the runner's body: an abnormality no one had ever looked for. The race does not create the risk; it is the moment the pre-existing risk is pushed past its threshold. If that is right, the focus of any safety discussion should sit not at the start line, but in a clinic months earlier. The issue is not making the marathon safer by shortening the distance or banning participation, but detecting abnormal hearts before they step onto the course. There is a second, subtler paradox here. Mass races are often praised for their inclusivity: anyone can take part. That very inclusivity is the root of the screening gap. Because the door is open to everyone, no medical filter is placed at the door. And because there is no filter, those at highest risk are precisely those least warned. One more thing must be said plainly: caution in attributing cause is not evasion. When the media says sudden cardiac arrest, that is a description, not a diagnosis. Only a coroner's or medical examiner's finding can establish the true mechanism: a structural abnormality, an electrical disorder, myocarditis, or something else. Until that finding exists, any inference should remain at the level of hypothesis. As for the organiser, Motiv Sports confirmed that a medical emergency occurred but declined to provide athlete-specific detail. This is the standard posture on privacy and liability, consistent with how race organisers handle similar events. It is not a sign of fault. But it also leaves an information gap: we do not know the density of medical stations along the course, the response time, or whether an automated external defibrillator was used in time. Those facts can be decisive in saving someone who suffers cardiac arrest outside a hospital. I do not infer either adequacy or negligence in this race's medical infrastructure. I simply note that it has not been disclosed. At the industry level, this case sends a signal about safety and screening, rather than commerce. High-profile deaths at mass races tend to drive demand for cardiac screening and for on-course defibrillator readiness. They can influence insurance standards and event medical protocols. There is a mid-term spillover effect on wearables. Incidents like this strengthen the consumer case for sports watches capable of heart-rate monitoring and ECG recording. This is a directional inference, not a fact from the source, and should be read as such. And there is a less-discussed layer of infrastructure: community fundraising campaigns are themselves part of the mass-marathon ecosystem, acting as an informal social safety net that the formal system does not provide. In this case, a community fundraising campaign raised about sixty thousand dollars for Trey Lara's family. Trey Lara was not a name on a results board. He was a member of a community, someone who worked with young people. The community's response after his death reflected that. The sum raised shows the closeness of the network around him. This is the kind of evidence I always watch for: it tells you what a person meant to those around them, something no results board can record. No measurable impact on elite competition commercialisation, national-team systems, or the youth talent chain is discernible from a single case like this. For those domains, the information is insufficient for any claim. What I want to see next is not a wave of fear about the marathon, but a serious discussion about bringing cardiac screening closer to recreational runners — the people who make up the majority and are the least protected in this sport's pyramid. In an age of exploding data, I still believe in eyes, ears, and a heart that does not lie. Every athlete who passes me is a universe. I am only the one standing behind the door, recording their pulse. And the pulse of a twenty-five-year-old at mile 20 deserves to be heard before it stops.